United States Securities and Exchange Commission · EDGAR Accession 0002045356-26-000003

Form C-AR

Annual Report — Regulation Crowdfunding
Issuer CIK 2045356
Period 2025-12-31

Ignite Biomedical, Inc.

CorporationDEIncorporated 2022Framingham, MAignitebiomedical.com
B

Financial Condition

two fiscal years, as filed
Pre-revenueBurn increasingDebt / assets 246%2 employees
Line itemMost recent FYPrior FYΔ
Revenue00
Cost of goods sold00
Net income(2,103,505)(517,884)▼ burn
Total assets1,223,1021,233,658▼ 1%
Cash & equivalents223,102233,657▼ 5%
Accounts receivable00
Short-term debt6,9993,808▲ 84%
Long-term debt2,996,4000
Taxes paid456456

Figures in USD as reported by the issuer.